ArticleCancer management and research2020

MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC.

Qin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.